Once registered, you can:

  • - Read additional free articles each month
  • - Comment on articles and featured creative work
  • - Get our curated newsletters delivered to your inbox

By registering you agree to our privacy policy, terms & conditions and to receive occasional emails from Ad Age. You may unsubscribe at any time.

Are you a print subscriber? Activate your account.


Agency Declines Comment on Split

By Published on .

NEW YORK (AdAge.com) -- Interpublic Group of Cos.' Bozell, New York, has resigned its Excedrin account, the agency's president, Tom Bernardin, said today.

Mr. Bernardin would not comment on the reasons for the split or the brands handled by the agency at the relationship's end.

$47 million spent in 2001
Bristol-Myers Squibb, maker of Excedrin, spent $47 million in measured media on 12 Excedrin brands in 2001, according to Taylor Nelson Sofres' CMR. The marketer put most of its ad dollars against Excedrin Extra Strength Geltabs ($17.5 million) and Excedrin Migraine Pain Geltabs ($12.8 million).

Calls to New York-based Bristol-Myers Squibb were not returned at press time.

Most Popular